The Role of the Osteoprotegerin/RANKL/RANK System in Diabetic Vascular Disease

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|18|31|4813-4819

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.18, Iss.31, 2011-11, pp. : 4813-4819

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ectopic calcification in diabetic vascular disease

By Avogaro Angelo   Rattazzi Marcello   Fadini Gian Paolo  

Expert Opinion on Therapeutic Targets, Vol. 18, Iss. 5, 2014-05 ,pp. : 595-609

Informa Healthcare

Access to resources Recommend Favorite

Emerging therapeutic targets in diabetic vascular disease

By Schmidt A.M.   Stern D.M.  

Expert Opinion on Therapeutic Targets, Vol. 3, Iss. 3, 1999-09 ,pp. : 483-493

Informa Healthcare

Access to resources Recommend Favorite

Role of Asymmetric Dimethylarginine (ADMA) in Diabetic Vascular Complications

By  

Current Pharmaceutical Design, Vol. 14, Iss. 25, 2008-09 ,pp. : 2613-2618

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting RANK/RANKL in the Treatment of Solid Tumours and Myeloma

By  

Current Pharmaceutical Design, Vol. 16, Iss. 11, 2010-04 ,pp. : 1272-1283

Bentham Science Publishers

Access to resources Recommend Favorite

Role of estrogen receptors in the vascular system

By Rubanyi G.M.   Kauser K.   Johns A.  

General Pharmacology, Vol. 38, Iss. 2, 2002-02 ,pp. : 81-88

Elsevier

Access to resources Recommend Favorite